Citation Impact
Citing Papers
Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
2007 StandoutScience
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults.
2006 Standout
Natural history and prognostic factors for chronic hepatitis type B.
1991
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial
2005 Standout
Management of hepatitis B
2007
Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV–HCV International Panel
2002
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
T-cell-mediated autologous hepatocytotoxicity in patients with chronic hepatitis C virus infection
1995
Long-Term Outcome after Hepatitis B Surface Antigen Seroclearance in Patients with Chronic Hepatitis B
2006
Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan
2001
Serum α-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status
2001
Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients
1998
Hepatocellular carcinoma
2003 Standout
Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case–control study in Italy
2001
Predicting Cirrhosis Risk Based on the Level of Circulating Hepatitis B Viral Load
2006
Hepatitis B Virus Infection — Natural History and Clinical Consequences
2004 Standout
Interactions Between Human Immunodeficiency Virus–1, Hepatitis Delta Virus and Hepatitis B Virus Infections in 260 Chronic Carriers of Hepatitis B Virus
1992
Hepatitis B virus-related decompensated liver cirrhosis: Benefits of antiviral therapy
2012
Hepatitis flares and hepatitis B e antigen seroconversion: Implication in anti‐hepatitis B virus therapy1
2003
Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
2015 Standout
Hepatitis C Virus Infection
2001 Standout
Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: new trick of old dog
2012
Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver
1992
Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study
2002
Chronic hepatitis B viral infection independently predicts renal outcome in type 2 diabetic patients
2006
Epidemiological characteristics and risk factors of hepatocellular carcinoma
1997
Global Cancer Statistics, 2002
2005 Standout
Rising Incidence of Hepatocellular Carcinoma in the United States
1999 Standout
Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications
2004
Hepatitis B Virus Infection: Epidemiology and Vaccination
2006 Standout
Efficacy of thymosin α1 in patients with chronic hepatitis B: A randomized, controlled trial
1998
A Randomized, Controlled Study of Thymosin-α1 Therapy in Patients with Anti-HBe, HBV-DNA-Positive Chronic Hepatitis B
2000
Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
1998 Standout
Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy
1999
Meta‐analysis: treatment of hepatitis B infection reduces risk of hepatocellular carcinoma
2008
Analysis of cost‐effectiveness of different strategies for hepatocellular carcinoma screening in hepatitis B virus carriers
1992
Management of hepatitis B: 2000—Summary of a workshop
2001
Screening for hepatocellular carcinoma
1998
A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum
1997
Asian‐Pacific consensus statement on the management of chronic hepatitis B: An update*
2003
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update
2008
Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion
2006
Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection
2002
Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection☆
2004
Displacement of hepatitis B virus by hepatitis C virus as the cause of continuing chronic hepatitis
1994
Therapy of hepatitis C: Meta-analysis of interferon alfa-2b trials
1997
HBsAg seroclearance in asymptomatic carriers of high endemic areas
2007
Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications
2005
PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN ITALIAN PATIENTS WITH HEPATOCELLULAR CARCINOMA
1989 StandoutNobel
The clinical significance of persistently normal ALT in chronic hepatitis B infection
2007
Hepatocellular carcinoma
2012 Standout
Hepatitis B virus infection
2009 Standout
Chronic hepatitis B
2001
Natural course following the onset of cirrhosis in patients with chronic hepatitis B: a long-term follow-up study
2007
A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma
1998
Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study
1994
Natural history of chronic HBV infection: A cohort study with up to 12 years follow-up in North Greece (part of the Interreg I-II/EC-project)
2005
Natural History of Chronic Hepatitis B Virus Infection: What We Knew in 1981 and What We Know in 2005
2006
Can we use HCC risk scores to individualize surveillance in chronic hepatitis B infection?
2015
Genetics of hepatocellular carcinoma
2000
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
2004 Standout
Hepatitis B e antigen-negative chronic hepatitis B
2001
Hepatitis B vaccines
2003
Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma
2004
The RNA Sensor RIG-I Dually Functions as an Innate Sensor and Direct Antiviral Factor for Hepatitis B Virus
2014 StandoutNobel
Treatment of chronic hepatitis B
2001
Determinants of early mortality in patients with decompensated chronic hepatitis B treated with antiviral therapy
2002
Acute exacerbations in Chinese patients with chronic hepatitis B virus (HBV) infection
1990
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
2005 Standout
Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma—A randomized controlled trial
1988
Meta–Analysis of Interferon Randomized Trials in the Treatment of Viral Hepatitis C: Effects of Dose and Duration
1996
Natural history of hepatitis b e antigen to antibody seroconversion in patients with normal serum aminotransferase levels
2004
Clinical Implications of Alpha-fetoprotein in Chronic Hepatitis C
2009
Global cancer statistics
2011 Standout
Long-term follow-up of chronic hepatitis B patients treated with interferon alfa
1993
Palliative external-beam radiotherapy for bone metastases from hepatocellular carcinoma
2014
Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis
1990
Diabetes in Asia
2009 Standout
Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B
2002
Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B
2004
Long‐term outcome of chronic hepatitis B based on histological grade and stage
2007
Occurrence of hepatocellular carcinoma and decompensation in western european patients with cirrhosis type B
1995
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
2001 Standout
HBsAg seroclearance in chronic hepatitis B in the Chinese: Virological, histological, and clinical aspects
2004
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
2004 Standout
An Algorithm for the Grading of Activity in Chronic Hepatitis C
1996 Standout
Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
1996 Standout
Seropositivity of hepatitis B e antigen and hepatocellular carcinoma
2004
Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: A prospective study of 626 patients with identification of risk factors
2000
Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level
2006 Standout
Chronic hepatitis B
2007 Standout
Effects of entecavir and lamivudine for hepatitis B decompensated cirrhosis: Meta-analysis
2013
Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma
2006
The natural history of chronic hepatitis B virus infection #
2009
Hepatocellular Carcinoma in Italian Patients with Cirrhosis
1991
Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy
2004
Prospective Analysis of Risk Factors for Hepatocellular Carcinoma in Patients With Liver Cirrhosis
2003
The long-term course of chronic hepatitis B
1999
Chronic hepatitis B: Update 2009 #
2009 Standout
Hepatitis C virus-specific T lymphocyte responses
1995 StandoutNobel
Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis
1999
Role of viral factors in the natural course and therapy of chronic hepatitis B
2007
Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase
2003
Thymosin α1 treatment of chronic hepatitis B: results of a phase III multicentre, randomized, double‐blind and placebo‐controlled study
1999
Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B
2000
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial
2002 Standout
Enhanced Activation of Memory, but Not Naïve, B Cells in Chronic Hepatitis C Virus-Infected Patients with Cryoglobulinemia and Advanced Liver Fibrosis
2013 StandoutNobel
Then and now: The progress in hepatitis B treatment over the past 20 years
2014
Classification of chronic viral hepatitis: a need for reassessment
1991
Predictive Factors for Reactivation of Hepatitis B Following Hepatitis B e Antigen Seroconversion in Chronic Hepatitis B
2007
Clinical Utility of AFP-L3% Measurement in North American Patients with HCV-Related Cirrhosis
2007
Efficacy of Lamivudine in Patients With Hepatitis B E Antigen-Negative/Hepatitis B Virus Dna-Positive (Precore Mutant) Chronic Hepatitis Befficacy of Lamivudine in Patients With Hepatitis B E Antigen-Negative/Hepatitis B Virus Dna-Positive (Precore Mutant) Chronic Hepatitis Befficacy of Lamivudine in Patients With Hepatitis B E Antigen-Negative/Hepatitis B Virus Dna-Positive (Precore Mutant) Chronic Hepatitis Befficacy of Lamivudine in Patients With Hepatitis B E Antigen-Negative/Hepatitis B Virus Dna-Positive (Precore Mutant) Chronic Hepatitis Bb
1999
Long–Term Beneficial Effect of Interferon Therapy in Patients With Chronic Hepatitis B Virus Infection
1999
The HEP-NET B/C co-infection trial: A prospective multicenter study to investigate the efficacy of pegylated interferon-α2b and ribavirin in patients with HBV/HCV co-infection
2008
Acute Exacerbation of Chronic Hepatitis B Virus Infection After Withdrawal of Lamivudine Therapy
2000
A One-Year Trial of Lamivudine for Chronic Hepatitis B
1998
Clinical course after stopping lamivudine in chronic hepatitis B patients with lamivudine‐resistant mutants
2004
Interferon therapy in chronic hepatitis C virus infection
1994
Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis
1998
Hepatitis E Virus and Chronic Hepatitis in Organ-Transplant Recipients
2008 Standout
Crystal Structure of the Hepatitis C Virus NS3 Protease Domain Complexed with a Synthetic NS4A Cofactor Peptide
1996 StandoutNobel
Viruses and hepatocellular carcinoma.
1994
Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients
2002
The effect of lamivudine therapy in hepatic decompensation during acute exacerbation of chronic hepatitis B
2003
High Doses of alpha-Interferon Are Required in Chronic Hepatitis Due to Coinfection With Hepatitis B virus and hepatitis C virus: long term results of a prospective randomized trial
2001
Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study
1997
Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance
2004
Lymphoblastoid interferon alfa with or without steroid pretreatment in children with chronic hepatitis B: A multicenter controlled trial
1996
Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy
1991
The Risk of Transfusion-Transmitted Viral Infections
1996 Standout
Natural history of liver fibrosis progression in patients with chronic hepatitis C
1997 Standout
Asian‐Pacific consensus statement on the management of chronic hepatitis B: a 2005 update
2005
Spontaneous relapse of hepatitis in inactive HBsAg carriers
2007
Genotype C hepatitis B virus infection is associated with a higher risk of reactivation of hepatitis B and progression to cirrhosis than genotype B: A longitudinal study of hepatitis B e antigen-positive patients with normal aminotransferase levels at baseline
2005
A long-term follow-up study of asymptomatic hepatitis B surface antigen—Positive carriers in montreal
1994
Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
1998 Standout
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Treatment of hepatocellular carcinoma with tamoxifen: A double-blind placebo-controlled trial in 120 patients
1995
Prospective Study of Hepatocellular Carcinoma and Liver Cirrhosis in Asymptomatic Chronic Hepatitis B Virus Carriers
1997
Hepatocellular Carcinoma
2011 Standout
Genomics and Signaling Pathways in Hepatocellular Carcinoma
2007
Hepatitis C: Natural History of a Unique Infection
1995
Serum alpha-fetoprotein levels in patients with advanced hepatitis C: Results from the HALT-C Trial
2005
Prednisone-interferon combination in the treatment of chronic hepatitis B: Direct and indirect metanalysis
1994
Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B
2002
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
HBsAg Seroclearance in Chronic Hepatitis B in Asian Patients: Replicative Level and Risk of Hepatocellular Carcinoma
2008
Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infection
2000
Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis
2001
Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults
1987
Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study
1994
Hepatocellular Carcinoma
2019 Standout
Serologic and Clinical Outcomes of 1536 Alaska Natives Chronically Infected with Hepatitis B Virus
2001
Natural History of Chronic Hepatitis B Virus Infection in Taiwan: Studies of Hepatitis B Virus Dna in Serum
1985
A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP): Part 1: Immunization of Infants, Children, and Adolescents
2005
Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia
2007 StandoutNobel
Clinical and Histological Events Preceding Hepatitis B e Antigen Seroconversion in Chronic Type B Hepatitis
1983
Successful withdrawal of antiviral treatment in kidney transplant recipients with chronic hepatitis B viral infection
2014
Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C
2005 StandoutNobel
N,N-DIMETHYLFORMAMIDE: HAZARD CHARACTERIZATION AND EXPOSURE–RESPONSE ANALYSIS
2001
A Randomized, Controlled Trial of Combination Therapy for Chronic Hepatitis B: Comparing Pegylated Interferon-α2b and Lamivudine with Lamivudine Alone
2005
Hepatocellular Carcinoma
1988
Precore Stop Mutant in HBeAg-Positive Patients with Chronic Hepatitis B: Clinical Characteristics and Correlation with the Course of HBeAg-to-Anti-HBe Seroconversion
2002
Changes of serum hepatitis B virus DNA in two types of clinical events preceding spontaneous hepatitis B e antigen seroconversion in chronic type B hepatitis
1987
Which Patients With Chronic Hepatitis B Virus Infection Will Respond to α–Interferon Therapy? A Statistical Analysis of Predictive Factors
1989
Oral antiviral therapy improves the diagnostic accuracy of alpha‐fetoprotein levels in patients with chronic hepatitis B
2014
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Luminescent metal–organic frameworks for chemical sensing and explosive detection
2014 Standout
Treatment of chronic type B and C hepatitis with interferon alfa: An economic appraisal
1995
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors
2007
Cost-effectiveness of interferon-?2b treatment for hepatitis B e antigen-Positive chronic hepatitis Wong JB, Koff RS, Tine F, Pauker SG. B. Ann Intern Med 1995; 122: 664?675
1995
Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection
1987
Pathogenic role of hepatitis B virus in hepatitis B surface antigen—negative decompensated cirrhosis
1995
Hepatitis B Virus Replication and Liver Disease Progression: The Impact of Antiviral Therapy
2006
Accumulation of B Lymphocytes with a Naive, Resting Phenotype in a Subset of Hepatitis C Patients
2003 StandoutNobel
Clinical features and treatment efficacy of peginterferon alfa plus ribavirin in chronic hepatitis C patients coinfected with hepatitis B virus
2011
Interferon-α for HBeAg-positive chronic hepatitis B
2003
Factors influencing liver disease progression in chronic hepatitis B
2006
Characterization of Hepatitis C Virus Core-Specific Immune Responses Primed in Rhesus Macaques by a Nonclassical ISCOM Vaccine
2001 StandoutNobel
Liver-Derived CTL in Hepatitis C Virus Infection: Breadth and Specificity of Responses in a Cohort of Persons with Chronic Infection
1998 StandoutNobel
Works of Tong‐Jong Chen being referenced
Comparison of liver histopathology between chronic hepatitis C patients and chronic hepatitis B and C‐coinfected patients
2006
Effects of prednisolone pretreatment in interferon alfa therapy for patients with chronic non‐A, non‐B (C) hepatitis
1993
The development of cirrhosis in patients with chronic type B hepatitis: A prospective study
1988
The prognostic significance of bridging hepatic necrosis in chronic type B hepatitis: a histopathologic study
1988
A new mutational hot-spot in the p53 gene in human hepatocellular carcinoma
1994
Beneficial effect of prednisolone withdrawal followed by human lymphoblastoid interferon on the treatment of chronic type B hepatitis in Asians: a randomized controlled trial
1994
Hepatocellular carcinoma presenting as bone metastasis
1989
Acute exacerbation in patients with liver cirrhosis: a clinicopathological study
1990
Concurrent hepatitis C virus and hepatitis delta virus superinfection in patients with chronic hepatitis B virus infection
1992
Hepatitis B X-gene expression in hepatocellular carcinoma
1992
Acute hepatitis delta virus superinfection in patients with liver cirrhosis
1990
A reappraisal of cholangiocarcinoma in patient with hepatolithiasis
1993
Natural course after the development of cirrhosis in patients with chronic type B hepatitis: a prospective study
1989
Natural course of patients with chronic type B hepatitis following acute hepatitis delta virus superinfection
1989
Detection of hepatitis B and C viruses in liver tissue with hepatocellular carcinoma
1994
Dimethylformamide-induced occupational liver injury--a case report.
1998
Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: A prospective study
1991
Spontaneous regression of hepatocellular carcinoma.
1992
Chronic hepatitis with nonspecific histological changes. Is it a distinct variant of chronic hepatitis?
1984
Alpha‐fetoprotein changes in the course of chronic hepatitis: relation to bridging hepatic necrosis and hepatocellular carcinoma
1986
Acute exacerbation in hepatitis B e antigen positive chronic type B hepatitis
1985
Acute exacerbation in chronic type B hepatitis: Comparison between HBeAg and antibody-positive patients
1987
Intracranial Phycomycosis: Case Reports
1988
Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis
1986
Chronic Lobular Hepatitis: A Clinicopathological and Prognostic Study
1982